Effects of Ferric Carboxymaltose vs Ferumoxytol on Hypophosphatemia in Patients With IronDeficiency Anemia Due to Gastrointestinal Disorders

被引:0
|
作者
Dahl, Naomi V. [1 ]
Sadiq, Amama [1 ]
机构
[1] AMAG Pharmaceut Inc, Waltham, MA USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1268
引用
收藏
页码:S636 / S637
页数:3
相关论文
共 50 条
  • [1] Hypophosphatemia in HFrEF patients after iron supplementation. Ferric carboxymaltose vs Ferric derisomaltose
    Panagiotides, N.
    Weidenhammer, A.
    Arfsten, H.
    Prausmueller, S.
    Spinka, G.
    Bartko, P.
    Goliasch, G.
    Huelsmann, M.
    Pavo, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 95 - 96
  • [2] Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
    Wolf, Myles
    Rubin, Janet
    Achebe, Maureen
    Econs, Michael J.
    Peacock, Munro
    Imel, Erik A.
    Thomsen, Lars L.
    Carpenter, Thomas O.
    Weber, Thomas
    Brandenburg, Vincent
    Zoller, Heinz
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (05): : 432 - 443
  • [3] SEVERE HYPOPHOSPHATEMIA INDUCED BY FERRIC CARBOXYMALTOSE IN A PATIENT WITH IRON DEFICIENCY ANEMIA
    Abdelgadir, Yasir
    Abdelgadir, Eman
    Cheungpasitporn, Wisit
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [4] The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
    Koduru, Pramoda
    Abraham, Bincy P.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (01) : 76 - 85
  • [5] A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia
    Mundy, Linda M.
    Wohlfeil, Stefan
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E231 - E232
  • [6] Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients
    Santulario-Verdu, L.
    Echeverry-Navarrete, E.
    Diez-Lopez, C.
    Canedo-Castelo, M.
    Juvany-Roig, R.
    Garcia-Romero, E.
    Roca-Elias, J.
    Manito-Lorite, N.
    Gonzalez-Costello, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S220 - S221
  • [7] Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
    Adkinson, N. Franklin
    Strauss, William E.
    Macdougall, Iain C.
    Bernard, Kristine E.
    Auerbach, Michael
    Kaper, Robert F.
    Chertow, Glenn M.
    Krop, Julie S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) : 683 - 690
  • [8] Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect
    Sanchez Gonzalez, Rebeca
    Guillermo Ternavasio-de la Vega, Hugo
    Moralejo Alonso, Leticia
    Ines Revuelta, Sandra
    Fuertes Martin, Aurelio
    MEDICINA CLINICA, 2015, 145 (03): : 108 - 111
  • [9] Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose
    Schaefer, Benedikt
    Zoller, Heinz
    Wolf, Myles
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : 1009 - 1019
  • [10] Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding
    Ballester-Clau, Raquel
    Torres Vicente, Gisela
    Volta-Pardo, Tania
    Lopez-Barroso, Laura
    Cucala-Ramos, Mercedes
    Rene-Espinet, Josep M.
    Planella de Rubinat, Montse
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 116 - 122